Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COPZ2 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | HEXA | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-10 |
mRNA | SLIT3 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
mRNA | C9 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | RAB11FIP5 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | B4GALT7 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
mRNA | PSAP | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | LEPROT | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |